Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 6, Issue 2, 2006, Pages 183-187

  Paskins, Z ^a   Potter, T ^b   Erb, N ^c   Obrenovic, K ^c   Rowe, I F ^b,d  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

^c DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^d WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Corticosteroid induced osteoporosis; Guidelines; Regional audit

Indexed keywords

PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OSTEOPOROSIS; PRACTICE GUIDELINE; RHEUMATIC DISEASE;

EID: 33646108581     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.6-2-183     Document Type: Article

References (22)

1. Vestergaard P, Olsen ML, Paaske-Johnsen S, Rejnmark L et al. Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 2003;254:486-93.
2. Van-Everdingen AA, Jacobs JWG, Siewertsz-Van-Reesema DR, Bijlsma JWJ. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
3. Erb N, Duncan RC, Raza K, Rowe IF et al. A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands. Rheumatology 2002;41:1021-4.
4. Walker-Bone K, Wood A, Hull RG, Ledingham JM et al. The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice. Clin Med 2004;4:431-6.
5. Hart SR, Green B. Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe. Postgrad Med J 2002;78:242-3.
6. Kirchgatterer A, Wenzl HH, Aschl G, Hinterreiter M et al. Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality. Acta Med Austriaca 2002;29:120-3.
7. McClean H, Haworth P, Clarke J. Yorkshire Multi-District Genitourinary Medicine Clinical Audit Group. Accelerating the audit cycle: data gathering, analysis and dissemination of results by electronic methods. The third Yorkshire audit of genital chlamydial management. Int J STD AIDS 2004;15:767-71.
8. Aslam N, Mirza S, Lo S. Regional audit: perioperative management of MRSA orthopaedic patients in the Oxford region. Int J Clin Pract 2004;58:523-6.
9. Malik MH, Gambhir AK, Bale L, Pradhan N, Porter ML. Primary total hip replacement: a comparison of a nationally agreed guide to best practice and current surgical technique as determined by the North West Regional Arthroplasty Register. Ann R Coll Surg Engl 2004;86:113-8.
10. Lee R, Monteiro EF. Yorkshire Audit Group for HIV Related Diseases. Third regional audit of antiretroviral prescribing in HIV patients. Int J STD AIDS 2003;14:58-60.
11. National Osteoporosis Society. Guidance on the prevention and management of corticosteroid induced osteoporosis. Camerton, Bath: National Osteoporosis Society, 1998.
12. Royal College of Physicians. Glucocorticoid-induced osteoporosis: A concise guide to prevention and treatment. London: RCP, 2002.
13. Franchimont N, Canalis E. Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease. Autoimmun Rev 2003;2:224-8.
14. Dolan AL, Koshy E, Waker M, Goble CM. Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients. Ann Rheum Dis 2004;63:183-6.
15. Feldsteinn AC, Nichols GA, Elmer PJ, Smith DH et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am 2003;85-A:2294-302.
16. Jaglal SB, McIsaac WJ, Hawker G, Carroll J et al. Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 2003;14:672-6.
17. Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol 2004;31:550-6.
18. Sheldon TA, Cullum N, Dawson D, Lankshear A et al. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004;329:999-1007.
19. Samanta A, Goh L, Bawendi A. Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance. Rheumatology 2004;43:346-8.
20. Steinman MA, Fischer MA, Shlipak MG, Bosworth HB et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004;117:747-54.
21. Solomon DH, Katz JN, La Tourette AM, Coblyn JS. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 2004;51:383-7.
22. Portelli R, Lowe D, Irwin P, Pearson M, Rudd AG. Intercollegiate Stroke Working Party. Institutionalization after stroke. Clin Rehab 2005;19:97-108.